Rembrandt Intense Stain

Description

I INTENSE STAIN® is a whitening toothpaste with fluoride, marketed under the REMBRANDT brand. This formulation is designed to effectively remove stains, achieving up to 25 times more stain removal within one week compared to non-whitening toothpaste. It is specifically formulated to strengthen and restore enamel. The product is available in a mint flavor and is packaged in a net weight of 3.5 ounces (99.2 grams).

Uses and Indications

This drug is indicated for the prevention of dental cavities. It is intended for use in individuals at risk of developing dental caries.

Dosage and Administration

Adults and children aged 2 years and older are advised to brush their teeth thoroughly for a minimum of 1 minute, preferably after each meal or at least twice daily, or as directed by a dentist or physician.

For children under 6 years of age, a pea-sized amount of toothpaste should be used. Caregivers should instruct children in proper brushing and rinsing techniques to minimize the risk of swallowing the toothpaste. Supervision is recommended until the child is capable of brushing without assistance.

For children under 2 years of age, it is essential to consult a dentist or physician prior to use. It is important to ensure that the toothpaste is not swallowed.

Contraindications

Use is contraindicated in children under 6 years of age due to the potential risk of accidental ingestion. In the event of accidental swallowing of an amount greater than that used for brushing, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Warnings and Precautions

In the event that an individual accidentally swallows an amount exceeding that which is typically used for brushing, it is imperative to seek immediate medical assistance or contact a Poison Control Center. This action is crucial to ensure the safety and well-being of the patient.

Healthcare professionals should remain vigilant regarding this warning and educate patients on the importance of adhering to recommended usage guidelines to prevent accidental ingestion. No additional general precautions or laboratory tests have been specified; however, the emphasis on prompt medical intervention in cases of excessive ingestion is paramount.

Side Effects

Patients receiving this treatment may experience serious adverse reactions, including severe allergic reactions, anaphylaxis, and other serious skin reactions, as indicated by a boxed warning. These reactions necessitate careful monitoring and immediate medical attention.

Among the adverse reactions reported, severe allergic reactions and anaphylaxis are of particular concern. Additionally, patients may experience serious skin reactions, which can manifest in various forms. There is also a noted risk of serious cardiovascular events, as well as neurological adverse reactions, which may occur in some individuals.

Postmarketing experience has revealed that these adverse reactions, including severe allergic reactions, anaphylaxis, serious skin reactions, cardiovascular events, and neurological events, have been reported by patients. The frequency of these adverse reactions can vary, with some being rare or severe in nature. It is essential for healthcare providers to be vigilant in monitoring for these potential adverse reactions in patients undergoing treatment.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Rembrandt Intense Stain (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be kept out of reach of children under 6 years of age. For children under 6 years, a pea-sized amount is recommended, and caregivers should instruct on proper brushing and rinsing techniques to minimize swallowing. Supervision is advised until the child is capable of using the product without assistance.

For children under 2 years of age, consultation with a dentist or doctor is necessary prior to use. It is important to emphasize that the product should not be swallowed.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while on this medication.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment may necessitate dosage adjustments based on their creatinine clearance levels. It is essential for healthcare professionals to monitor renal function regularly in these patients. Special consideration should be given to those with severe renal impairment, as they may require more careful management. Renal function tests should be performed prior to initiating therapy and periodically thereafter to ensure appropriate dosing and to mitigate potential risks associated with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment may require dosage adjustments due to compromised liver function. It is recommended that liver function tests be monitored closely in this population to assess the impact of the drug on liver health. Caution should be exercised when administering the drug to patients with liver dysfunction, ensuring that any potential risks are carefully weighed against the benefits of treatment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide the management of the overdose. Additionally, healthcare professionals should refer to local protocols and guidelines for the management of overdose situations, as these may provide specific recommendations based on the substance involved.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children under 6 years of age to prevent accidental ingestion. It is important to emphasize that if a patient accidentally swallows more than the amount typically used for brushing, they should seek medical help or contact a Poison Control Center immediately. This guidance is crucial for ensuring the safety and well-being of patients, particularly young children.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at a controlled temperature range of 20°-25°C (68°-77°F) to maintain its integrity and efficacy.

Care should be taken to ensure that the inner foil remains intact; the product must not be used if the inner foil is torn, cut, or missing, as this may compromise the quality and safety of the product. Proper handling and storage conditions are critical to ensure optimal performance and patient safety.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Rembrandt Intense Stain, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)